4//SEC Filing
Teufel Crispin 4
Accession 0001104659-23-069902
CIK 0001600132other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:10 PM ET
Size
5.7 KB
Accession
0001104659-23-069902
Insider Transaction Report
Form 4
Teufel Crispin
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-06-07−14,607→ 14,607 totalExercise: $0.83Exp: 2033-06-07→ Common Stock (14,607 underlying)
Footnotes (2)
- [F1]This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023.
- [F2]This option vests in full on June 7, 2024.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001771517
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:10 PM ET
- Size
- 5.7 KB